Schrodinger Inc. (SDGR): Price and Financial Metrics


Schrodinger Inc. (SDGR): $25.30

0.16 (+0.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SDGR POWR Grades

  • Momentum is the dimension where SDGR ranks best; there it ranks ahead of 46.95% of US stocks.
  • The strongest trend for SDGR is in Quality, which has been heading down over the past 179 days.
  • SDGR's current lowest rank is in the Value metric (where it is better than 9.18% of US stocks).

SDGR Stock Summary

  • SDGR's went public 2.99 years ago, making it older than only 15.18% of listed US stocks we're tracking.
  • With a price/sales ratio of 10.12, SCHRODINGER INC has a higher such ratio than 88.31% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, SCHRODINGER INC is reporting a growth rate of 89.19%; that's higher than 84.63% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to SCHRODINGER INC are ENTX, DYAI, PSNL, VLDR, and TARS.
  • Visit SDGR's SEC page to see the company's official filings. To visit the company's web site, go to www.schrodinger.com.

SDGR Valuation Summary

  • SDGR's EV/EBIT ratio is -10.7; this is 154.04% lower than that of the median Technology stock.
  • Over the past 36 months, SDGR's price/earnings ratio has gone up 49.3.

Below are key valuation metrics over time for SDGR.

Stock Date P/S P/B P/E EV/EBIT
SDGR 2023-01-27 9.6 3.5 -10.7 -10.7
SDGR 2023-01-26 9.6 3.5 -10.7 -10.6
SDGR 2023-01-25 9.6 3.5 -10.7 -10.7
SDGR 2023-01-24 9.5 3.5 -10.6 -10.5
SDGR 2023-01-23 10.0 3.7 -11.1 -11.1
SDGR 2023-01-20 9.7 3.6 -10.8 -10.7

SDGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SDGR has a Quality Grade of C, ranking ahead of 26.23% of graded US stocks.
  • SDGR's asset turnover comes in at 0.167 -- ranking 212th of 681 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows SDGR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.167 0.517 -0.083
2021-03-31 0.181 0.561 -0.025
2020-12-31 0.203 0.587 -0.074
2020-09-30 0.263 0.595 -0.086
2020-06-30 0.376 0.583 -0.243
2019-12-31 0.620 0.574 -0.435

SDGR Price Target

For more insight on analysts targets of SDGR, see our SDGR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $87.60 Average Broker Recommendation 1.33 (Strong Buy)

SDGR Stock Price Chart Interactive Chart >

Price chart for SDGR

SDGR Price/Volume Stats

Current price $25.30 52-week high $37.25
Prev. close $25.14 52-week low $15.85
Day low $25.30 Volume 1,182
Day high $25.30 Avg. volume 587,336
50-day MA $19.96 Dividend yield N/A
200-day MA $24.92 Market Cap 1.80B

Schrodinger Inc. (SDGR) Company Bio


Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development


SDGR Latest News Stream


Event/Time News Detail
Loading, please wait...

SDGR Latest Social Stream


Loading social stream, please wait...

View Full SDGR Social Stream

Latest SDGR News From Around the Web

Below are the latest news stories about SCHRODINGER INC that investors may wish to consider to help them evaluate SDGR as an investment opportunity.

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, January 20, 2023--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on January 16, 2023, the company granted (i) non-statutory stock options to purchase an aggregate of 14,300 shares of the company’s common stock to six newly hired employees, including three newly hired employees based outside of the United States and (ii) restricted stock units (RSUs) with respect to 4,350

Yahoo | January 20, 2023

Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities

NEW YORK, January 09, 2023--Schrödinger provided an update on its progress across the business and announced its strategic priorities for 2023.

Yahoo | January 9, 2023

Why These 7 Healthcare Stocks Could Soar in 2023

These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.

Muslim Farooque on InvestorPlace | January 2, 2023

7 Drug Stocks That Will Soar in 2023

These drug stocks to buy look poised to generate huge profits for investors., both in 2023 and in subsequent years.

Larry Ramer on InvestorPlace | December 22, 2022

Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting

NEW YORK, December 12, 2022--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced new preclinical data on its potent and selective CDC7 inhibitor, SGR-2921, in a poster session at the American Society of Hematology (ASH) 64th Annual Meeting taking place virtually and in New Orleans, Louisiana. The data presented demonstrate that SGR-2921 exhibits strong anti-tumor activity in vivo across mu

Yahoo | December 12, 2022

Read More 'SDGR' Stories Here

SDGR Price Returns

1-mo 38.18%
3-mo 20.94%
6-mo -24.66%
1-year -9.87%
3-year N/A
5-year N/A
YTD 35.37%
2022 -46.34%
2021 -56.01%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8024 seconds.